BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 30008251)

  • 1. Human placental membrane as a wound cover for chronic diabetic foot ulcers: a prospective, postmarket, CLOSURE study.
    Pacaccio DJ; Cazzell SM; Halperin GJ; Kasper MA; Neutel JM; O'Carroll BD; Reyzelman AM
    J Wound Care; 2018 Jul; 27(Sup7):S28-S37. PubMed ID: 30008251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentre prospective randomised controlled comparative parallel study of dehydrated human umbilical cord (EpiCord) allograft for the treatment of diabetic foot ulcers.
    Tettelbach W; Cazzell S; Sigal F; Caporusso JM; Agnew PS; Hanft J; Dove C
    Int Wound J; 2019 Feb; 16(1):122-130. PubMed ID: 30246926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of diabetic foot ulcers with dehydrated amniotic membrane allograft: a prospective case series.
    Abdo RJ
    J Wound Care; 2016 Jul; 25(Sup7):S4-S9. PubMed ID: 29027851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, multicentre, open-label, single-arm clinical trial for treatment of chronic complex diabetic foot wounds with exposed tendon and/or bone: positive clinical outcomes of viable cryopreserved human placental membrane.
    Frykberg RG; Gibbons GW; Walters JL; Wukich DK; Milstein FC
    Int Wound J; 2017 Jun; 14(3):569-577. PubMed ID: 27489115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic Skin Substitutes Versus Human Placental Membrane Products in the Management of Diabetic Foot Ulcers: A Narrative Comparative Evaluation of the Literature.
    Luck J; Rodi T; Geierlehner A; Mosahebi A
    Int J Low Extrem Wounds; 2019 Mar; 18(1):10-22. PubMed ID: 30663450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Retrospective Case Series of a Dehydrated Amniotic Membrane Allograft for Treatment of Unresolved Diabetic Foot Ulcers.
    Rosenblum BI
    J Am Podiatr Med Assoc; 2016 Sep; 106(5):328-337. PubMed ID: 27439322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
    Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
    Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of viable cryopreserved placental membranes for management of diabetic foot ulcers in a real world setting.
    Raspovic KM; Wukich DK; Naiman DQ; Lavery LA; Kirsner RS; Kim PJ; Steinberg JS; Attinger CE; Danilkovitch A
    Wound Repair Regen; 2018 Mar; 26(2):213-220. PubMed ID: 29683538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR; Reyzelman A; Kawalec J; French M
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics.
    Tettelbach W; Cazzell S; Reyzelman AM; Sigal F; Caporusso JM; Agnew PS
    Int Wound J; 2019 Feb; 16(1):19-29. PubMed ID: 30136445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prospective, Descriptive Study to Assess the Clinical Benefits of Using Calendula officinalis Hydroglycolic Extract for the Topical Treatment of Diabetic Foot Ulcers.
    Buzzi M; de Freitas F; Winter M
    Ostomy Wound Manage; 2016 Mar; 62(3):8-24. PubMed ID: 26978856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective clinical study of 188 consecutive patients to examine the effectiveness of a biologically active cryopreserved human skin allograft (TheraSkin®) on the treatment of diabetic foot ulcers and venous leg ulcers.
    Landsman AS; Cook J; Cook E; Landsman AR; Garrett P; Yoon J; Kirkwood A; Desman E
    Foot Ankle Spec; 2011 Feb; 4(1):29-41. PubMed ID: 21135263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative-pressure wound therapy for management of chronic neuropathic noninfected diabetic foot ulcerations - short-term efficacy and long-term outcomes.
    Borys S; Hohendorff J; Koblik T; Witek P; Ludwig-Slomczynska AH; Frankfurter C; Kiec-Wilk B; Malecki MT
    Endocrine; 2018 Dec; 62(3):611-616. PubMed ID: 30099674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Wound Closure Rates Using a Human Fibroblast-derived Dermal Substitute Versus a Fetal Bovine Collagen Dressing: A Retrospective Study.
    Fitzgerald RH; Sabolinski ML; Skornicki M
    Wound Manag Prev; 2019 Sep; 65(9):26-34. PubMed ID: 31702990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
    DiDomenico LA; Orgill DP; Galiano RD; Serena TE; Carter MJ; Kaufman JP; Young NJ; Jacobs AM; Zelen CM
    Int Wound J; 2018 Dec; 15(6):950-957. PubMed ID: 30019528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose folic acid and its effect on early stage diabetic foot ulcer wound healing.
    Boykin JV; Hoke GD; Driscoll CR; Dharmaraj BS
    Wound Repair Regen; 2020 Jul; 28(4):517-525. PubMed ID: 32141182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and safety of Grafix(®) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial.
    Lavery LA; Fulmer J; Shebetka KA; Regulski M; Vayser D; Fried D; Kashefsky H; Owings TM; Nadarajah J;
    Int Wound J; 2014 Oct; 11(5):554-60. PubMed ID: 25048468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Prospective, Randomized, Multicenter, Controlled Evaluation of the Use of Dehydrated Amniotic Membrane Allograft Compared to Standard of Care for the Closure of Chronic Diabetic Foot Ulcer.
    Snyder RJ; Shimozaki K; Tallis A; Kerzner M; Reyzelman A; Lintzeris D; Bell D; Rutan RL; Rosenblum B
    Wounds; 2016 Mar; 28(3):70-7. PubMed ID: 26978860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unplanned 30-day readmission in patients with diabetic foot wounds treated in a multidisciplinary setting.
    Holscher CM; Hicks CW; Canner JK; Sherman RL; Malas MB; Black JH; Mathioudakis N; Abularrage CJ
    J Vasc Surg; 2018 Mar; 67(3):876-886. PubMed ID: 29017807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of a porcine peritoneum-derived matrix in diabetic foot ulcer treatment: a pilot study.
    Ai-Jalodi O; Sabo M; Patel K; Bullock N; Serena L; Breisinger K; Serena TE
    J Wound Care; 2021 Feb; 30(Sup2):S18-S23. PubMed ID: 33573495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.